Adverse Physical Health Outcomes and Healthcare Service Utilization in Siblings of Children With Cancer: A Systematic Review

Victorine Sirveaux, Lily Puterman‐Salzman, Yu Zhang, Eleni Sotirakos, Philippe Dodin, Guillaume Dumas, Eyal Cohen, Nadia Roumeliotis, Petros Pechlivanoglou, Hallie ColtinCancer 2025 · DOI

TL;DR

Siblings of children with cancer may face increased risks of adverse physical health outcomes and higher healthcare service utilization. However, existing research is highly varied, making it difficult to draw definitive conclusions or establish clear risk profiles. This systematic review highlights the need for more standardized research to better understand and address the health vulnerabilities of these siblings.

What Problem Does This Paper Address?

When a child is diagnosed with cancer, the entire family is affected. While much attention is rightly given to the child's well-being and treatment, the health of their siblings can be overlooked. Siblings may experience significant stress, emotional distress, and potentially adverse physical health consequences due to the disruption and demands of a sibling's cancer diagnosis. Previous research has suggested that siblings of children with chronic illnesses might be at higher risk for certain health issues. However, for siblings of children with cancer, the extent and nature of these physical health vulnerabilities and their patterns of healthcare utilization remain poorly understood. This paper aims to systematically review and synthesize the existing evidence to clarify these potential health risks.

Methods

This study employed a systematic review methodology to identify and analyze research on the physical health outcomes and healthcare service utilization among siblings of children with cancer. The researchers conducted a comprehensive search across multiple databases (Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials, CINAHL, and Clarivate Web of Science) up to June 15, 2024. They included English and French-language observational studies, with or without healthy control groups, that reported on specific adverse physical health outcomes (e.g., mortality, cancer, organ system diseases, infections) and healthcare service utilization (e.g., hospitalizations, emergency department visits, prescriptions). Studies focusing solely on mental health or quality of life were excluded. Two independent reviewers screened titles and abstracts, and then full-text articles. Data extraction and risk of bias assessment were performed using standardized tools. Due to significant heterogeneity in study designs, populations, and outcome measures, a narrative synthesis was used instead of meta-analyses.

Datasets

Not discussed in the paper. The paper is a systematic review of existing literature, not a primary data collection study.

Key Insights and Ideas

  • Siblings are a vulnerable population: The review strongly suggests that siblings of children with cancer are not immune to adverse health outcomes and may experience a higher burden of certain conditions and healthcare needs compared to the general population.
  • Heterogeneity is a major challenge: The most striking insight is the vast heterogeneity across studies. This includes differences in how siblings were defined, the types of cancer in the index child, the study designs, and how outcomes were measured. This makes it incredibly difficult to draw firm conclusions or compare findings directly.
  • Trends, not definitive risks: While meta-analyses were not possible, the review identified trends suggesting increased risks for cancer, hospitalizations, and prescription medication use in siblings. However, these trends are often based on limited data and significant variability.
  • Healthcare utilization is complex: Siblings may use healthcare services more, but they also appear to be more proactive in seeking preventive care, suggesting a nuanced relationship with the healthcare system.
  • Research gaps are significant: The review highlights a critical lack of studies that specifically focus on siblings as the primary population of interest, rather than using them as controls for cancer survivors. This means much of the existing data is not optimized for understanding sibling-specific risks.

Key Results

  • 44 studies were included out of over 51,000 initially identified records, involving a total of 84,637 siblings and 102,377 controls.
  • Cancer-related mortality: One study reported a significantly higher risk of cancer-related mortality in siblings (mortality rate ratio, 2.83; 95% CI, 1.41-5.67).
  • Cancer risk: While some studies found no significant increased risk of cancer in siblings, others reported an increased risk (e.g., SIR, 1.5; 95% CI, 1.3-1.7). Specific cancers like retinoblastoma and hepatoblastoma showed increased risk in some analyses.
  • Hospitalizations: Two studies indicated an increased risk of hospitalization in siblings (RR, 1.15; 95% CI, 1.02-1.29 and IRR, 1.1; 95% CI, 1.1-1.2). Specific conditions like nervous system, respiratory, and digestive disorders showed higher hospitalization risks.
  • Prescription medication use: One study found an excessive rate of prescriptions in siblings compared to controls (IRR, 1.97; 95% CI, 1.63-2.39).
  • Preventive care: Siblings were more likely to receive preventive healthcare, such as periodic health checkups and influenza vaccinations.
  • Overweight/Obesity: Prevalence varied widely, with some studies showing similar rates to controls and others reporting higher prevalence in siblings.

Limitations and Future Work

The authors acknowledge several significant limitations:

  • Study Heterogeneity: The most prominent limitation is the substantial heterogeneity in study populations (child's cancer type, sibling characteristics), study designs (retrospective vs. prospective, cohort vs. case-control), and outcome measurements and definitions. This prevented meta-analyses and limited the ability to draw definitive conclusions.
  • Data Sources: A large proportion of studies (72%) relied on self-reported data, which can introduce recall and response biases.
  • Lack of Matched Controls: Many studies did not use matched control groups specifically for siblings, making direct comparisons difficult.
  • Limited Longitudinal Data: Most studies were cross-sectional or retrospective, limiting the ability to assess the long-term impact of childhood cancer on siblings.
  • Inability to Stratify: The authors could not perform stratified analyses to determine the impact of specific factors (e.g., sibling age, child's cancer type) due to pooled sibling data.

Future Work: The authors strongly advocate for future research with homogenized methodology. This includes:

  • Using matched population controls specifically for siblings.
  • Conducting prospective, longitudinal studies to better characterize risks and predictive factors.
  • Developing standardized methodologies for data collection and outcome measurement.
  • Focusing on identifying at-risk subgroups of siblings.
  • Investigating the impact of confounding factors such as socioeconomic status, parental health, and shared environmental exposures.

This research aims to lay the groundwork for improved surveillance guidelines and targeted interventions for the long-term care of siblings of children with cancer.

Summary updated

Abstract

Siblings of children with cancer are likely vulnerable to various adverse health outcomes. However, the published literature is widely heterogeneous regarding study design, populations, and outcomes measurements, limiting our comprehensive analysis of risk. Future research with homogenized methodology is needed to better quantify risk, which would inform targeted surveillance guidelines and interventions.
BibTeX
@inproceedings{sirveaux2025adverse,
  author = {Victorine Sirveaux and Lily Puterman‐Salzman and Yu Zhang and Eleni Sotirakos and Philippe Dodin and Guillaume Dumas and Eyal Cohen and Nadia Roumeliotis and Petros Pechlivanoglou and Hallie Coltin},
  title = {{Adverse Physical Health Outcomes and Healthcare Service Utilization in Siblings of Children With Cancer: A Systematic Review}},
  booktitle = {Cancer},
  year = {2025},
  doi = {10.1002/cam4.71035},
}
Figure